The abstract is read at the publisher; the summary is JClub's.
APOL1 risk variants (G1 and G2) form voltage-dependent, non-selective cation pores at the plasma membrane in HEK-293 cells and human podocytes, with higher basal activity linked to haplotype-dependent cytotoxicity.
- Why it matters: The study addresses uncertainty about how APOL1 risk variants drive kidney disease in individuals of African ancestry, focusing on the membrane mechanisms that could explain toxicity.
- What they did: Using heterologous expression in HEK-293 cells and human podocytes, the authors combined genetic manipulation, electrophysiology, and microscopy to track vesicle-like transport via actin filaments and measure ion flux and cytosolic calcium.
- The result: Extracellular Ca2+ is the primary source of the cytosolic Ca2+ increase, and both the M1 (N264K) variant and the APOL1 inhibitor Inaxaplin protect cell viability by blocking APOL1-dependent intracellular Ca2+ influx.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.